1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients
(
- Contribution to journal › Article
-
Mark
Effect of Degarelix, a Gonadotropin-Releasing Hormone Receptor Antagonist for the Treatment of Prostate Cancer, on Cardiac Repolarisation in a Randomised, Placebo and Active Comparator Controlled Thorough QT/QTc Trial in Healthy Men
(
- Contribution to journal › Article
- 2016
-
Mark
Population Pharmacokinetic Modelling of FE 999049, a Recombinant Human Follicle-Stimulating Hormone, in Healthy Women After Single Ascending Doses
(
- Contribution to journal › Article
-
Mark
Characterisation of Population Pharmacokinetics and Endogenous Follicle-Stimulating Hormone (FSH) Levels After Multiple Dosing of a Recombinant Human FSH (FE 999049) in Healthy Women
(
- Contribution to journal › Article
- 2014
-
Mark
Pharmacokinetics and bioavailability of a new testosterone gel formulation in comparison to Testogel® in healthy men
(
- Contribution to journal › Article
-
Mark
Different pharmacokinetic and pharmacodynamic properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line
(
- Contribution to journal › Article
- 1999
-
Mark
Functional effects of neuropeptide Y receptors on blood flow and nitric oxide levels in the human nose
(
- Contribution to journal › Article
- 1997
-
Mark
Symptoms and signs of severe citalopram overdose
(
- Contribution to journal › Article